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ttp://dx.doi.org/10.1016/j.ajpath.2013.11.016Klotho deﬁciency is a characteristic feature of chronic kidney disease in which anemia and cardiovascular
complications are prevalent. Disruption of the Klotho gene in mice results in hypervitaminosis D and a syn-
drome resembling accelerated aging that includes osteopenia and vascular calciﬁcations. Given that the bone
microenvironment and its cellular components considerably inﬂuence hematopoiesis, in the present study, we
addressed the in vivo role of klotho in blood cell formation and differentiation. Herein, we report that genetic
ablation of Klotho in mice results in a signiﬁcant increase in erythropoiesis and a decrease in the hemato-
poietic stemcell pool size in thebonemarrow, leading to impaired hematopoietic stem cell homing in vivo. Our
data also suggest that high vitamin D levels are only partially responsible for these hematopoietic changes in
Klotho/ mice. Importantly, we found similar hematopoietic abnormalities in Klotho/ fetal liver cells,
suggesting that the effects of klotho in hematopoietic stem cell development are independent of the bone
microenvironment. Finally, injection of klotho protein results in hematopoietic changes opposite to the ones
observed in Klotho/ mice. These observations unveil a novel role for the antiaging hormone klotho in the
regulation of prenatal and postnatal hematopoiesis and provide new insights for the development of ther-
apeutic strategies targeting klotho to treat hematopoietic disorders associated with aging. (Am J Pathol
2014, 184: 827e841; http://dx.doi.org/10.1016/j.ajpath.2013.11.016)Supported in part by NIH grant P30DE020754 (to Dr. Nicola Partridge; a
portion was used to support D.S.).
Disclosures: None declared.Hematopoiesis is a complex and tightly regulated process of
blood cell formation that is hierarchically coordinated. During
normal hematopoiesis, diverse blood cell types are produced
by the bone marrow (BM) in a manner related to physiologic
requirement. Certain conditions may trigger additional pro-
duction of blood cells. When the oxygen content of body
tissues is low, the kidneys produce and release erythropoietin
(Epo), a hormone that stimulates the BM to produce more red
blood cells (RBCs). Aging is associated with disruption of
normal hematopoiesis, resulting in an increase in the preva-
lence of anemia, the emergence of hematopoietic malig-
nancies, and the development of leukemias.1,2 Deterioration
of vital organ function, such as kidney and heart, is also
associatedwith age-related changes, as seen in chronic kidney
disease (CKD) and cardiovascular disease (CVD).
The antiaging hormone klotho, predominantly expressed in
the kidneys, is emerging as a multifunctional protein regu-
lating vital cellular functions.3e5 Klotho was serendipitously
discovered by Kuro-o et al6 when they observed symptoms of
accelerated aging associatedwith amutation in a speciﬁc genestigative Pathology.
.in mice. Klotho exists in a membrane-bound form expressed
at high levels in the kidney and, to a lesser extent, in other
tissues, whereas a soluble form of klotho is secreted into
blood, urine, and cerebrospinal ﬂuid after cleavage of the
extracellular domain.7e10 Earlier studies convincingly de-
monstrate that membrane-bound klotho (a-klotho) is indis-
pensable for signaling of the phosphatonin ﬁbroblast growth
factor 23 and that secreted klotho functions as an endocrine
hormone responsible for the multiple organ defects observed
in Klotho/ mice.11e14
Maintaining mineral ion homeostasis is critical and in-
volves a delicate and concerted action between bone- and
kidney-derived endocrine factors that operate through a
complex feedback mechanism(s). Patients with CKD often
present with bone diseases, such as osteopenia, osteopo-
rosis, or osteomalacia, as a result of signiﬁcant derangement
Vadakke Madathil et alof mineral metabolism.15,16 In patients with CKD, failure of
appropriate ﬁbroblast growth factor 23/Klotho signaling
results in hyperphosphatemia and vascular calciﬁcations.17
Klotho expression is decreased progressively with loss of
renal function,18 whereas blood levels of ﬁbroblast growth
factor 23 are elevated and are associated with increased
CVD and mortality in these patients and in patients under-
going dialysis.19e22 Moreover, abnormal blood cell pro-
duction leading to severe anemia is a common complication
in CKD and CVD and is caused by insufﬁcient renal pro-
duction of Epo.23,24
Disruption of the Klotho gene in mice due to mutations or
inactivation (Klotho/mice) results in growth retardation and
early demise, osteopenia, extensive vascular calciﬁcations, and
skin atrophy, coupled with phosphate retention and hypervi-
taminosis D.6,13,25e27 Conversely, overexpression of Klotho
has been shown to rescue the klotho-deﬁcient phenotype and
extend the life span inmice, suggesting thatKlotho functions as
an aging suppressor gene in mammals.6,28 Loss of klotho is
further known to cause endothelial dysfunction by promoting
oxidative stress.29 It has been well appreciated that aging and
oxidative stress adversely affect hematopoiesis by altering the
niche functions.30,31 An earlier report has also highlighted that
klotho deﬁciency in mice results in reduced B lymphopoiesis,
suggesting changes in immune regulatory functions by klo-
tho.32 In addition, klotho expression at the mRNA level has
been found to be signiﬁcantly decreased in resting human
CD4þ lymphocytes proportionally to advancing age.33
Signals emanating from the BM microenvironment and
extrinsic soluble factors associated with the bone and marrow
milieu are known to modulate hematopoietic stem cell (HSC)
proliferation and differentiation.34,35 Identifying the contrib-
uting factors involved in the regulation of hematopoiesis is an
area of active research. Several lines of evidence highlight the
role of bone-forming cells, the osteoblasts, in the HSC niche;
postnatal depletion of osteoblasts negatively regulates theHSC
pool size in the BM, whereas an increase in osteoblast number
is associated with an augmentation in HSC number.36e39 In
addition, a series of advances indicate the importance of the
bone-resorbing osteoclasts in regulation of the HSC microen-
vironment. Osteoclasts actively participate in HSC mobi-
lization from the BM to the circulation and also promote
formation of the HSC niche by controlling the maturation of
osteoblasts.40e44 Not only do bone cells participate in the
regulation ofhematopoiesis but themineral content of the niche
may also have a key function in localization of adult hemato-
poiesis, as reported in studies showing involvement of the
calcium-sensing receptor and vitamin D signaling in this pro-
cess.45,46 Therefore, alterations in bone modeling and remod-
eling processes and/ormineralization seem to have a prominent
effect on the modulation or formation of the hematopoietic
niche. However, the regulation of mineral ion balance and
hematopoiesis still remains largely a naive area.
Because the bone environment and its components and
the process of aging are closely linked to the regulation of
hematopoiesis, and klotho deﬁciency is associated with a828marked defect in skeletal mineralization and premature aging-
like features, we hypothesized that klotho is involved in the
regulation of RBC production and differentiation. In the
present study, we demonstrate that loss of klotho severely
affects erythropoiesis and HSC number and function. More
important, we show that klotho affects hematopoiesis inde-
pendently of changes in the BM environment and that the
absence of klotho results in aberrant hematopoiesis prena-
tally, providing evidence for a novel and direct role for klotho
in hematopoietic development. Although the kidney is the
adult hematopoietic organ in zebra ﬁsh equivalent to
mammalian BM,47e49 the present data demonstrate for the
ﬁrst time, to our knowledge, a link between the kidney-bone-
hematopoiesis axes in the mammalian system and attest that
klotho is a key factor in the process of hematopoiesis.
Materials and Methods
Mice
Klothoheterozygousmice (Klothoþ/)were purchased from the
Mutant Mouse Regional Resource Center (University of
California, Davis, CA) and were interbred to obtainKlotho-null
mice (Klotho/). 1a(OH)ase heterozygous mice were a gift
from Dr. René St-Arnaud (Genetics Unit, Shriners Hospital,
Montreal, QC, Canada). Klotho heterozygous and 1a(OH)ase
heterozygous mice were bred to obtain Klotho//1a(OH)
ase/ double mutants. B6.SJL-Ptprca/BoyAiTac (CD45.1;
Ly5.1) mice were purchased from Taconic Farms Inc. (New
York, NY). All mice were kept on a light/dark (12 hours/12
hours) cycle at 23Cand received standard laboratory chow and
water ad libitum. Genomic DNA was obtained from tail snips,
and routine PCRwas performed to identify the genotypes. PCR
conditionswere as follows: klothodinitial denaturation at 94C
for 5 minutes, 35 cycles of denaturation at 94C for 1 minute,
annealing at 63C for 1 minute and extension at 72C for 30
seconds, and ﬁnal extension at 72C for 10 minutes; 1a(OH)
ased94C for 5 minutes, annealing at 56C for 1 minute and
extension at 72C for 1 minute, followed by ﬁnal extension at




CATCGCCTTCTATC-30; and 1a(OH)ase (forward and
reverse), 50-GCACCTGGCTCAGGTAGCTCTTC-30 and
50-GTCCCAGACAGAGACATCCGT-30. All the animals
weremaintained in theNewYorkUniversity (NYU)College of
Dentistry Animal Facility in accordance with the general
guidelines of the NYU School of Medicine Division of Labo-
ratoryAnimalResources.All the animal studieswere approved
by the NYU Institutional Animal Care and Use Committee.
Blood Collection and Hematologic Analysis
Peripheral blood was collected after euthanasia from 6-
week-old mice by cardiac puncture into EDTA-coated tubesajp.amjpathol.org - The American Journal of Pathology
Klotho Regulates Hematopoiesis(BD Biosciences, San Jose, CA) to prevent clotting. Blood
samples were then shipped overnight to Cornell University
Animal Health Diagnostic Center (Ithica, NY) for auto-
mated complete blood cell count.
Tissue Collection
BM was isolated from dissected tibiae and femora from 6-
week-old mice by ﬂushing in Iscove’s modiﬁed Dulbecco’s
medium (IMDM) (Sigma-Aldrich, St. Louis, MO) supple-
mented with 20% fetal bovine serum (20% IMDM) (HyClone;
Thermo Scientiﬁc, Wilmington, DE) through a 27-gauge nee-
dle (Becton Dickinson Co., Franklin Lakes, NJ). Marrow cells
were dispersed by manual agitation and then were ﬁltered to
remove foreign particles. Spleens from 6-week-old mice were
surgically removed and were homogenized into a cell sus-
pension in 20% IMDM. Timed pregnant Klothoþ/ female
mice were sacriﬁced at 15.5 days postcoitum, and fetal livers
were collected by caesarean section and were homogenized
into a cell suspension in 20% IMDM. Genomic DNA was
obtained from tail snips, and routine PCR as described previ-
ously herein was used to identify the genotypes of the embryos.
Flow Cytometry Analysis
Tissues were dissected from 6-week-old or E15.5 embryo
mice, and ﬂow cytometry analysis for peripheral blood, BM,
spleen, and fetal liver cells was performed in a BD FACSort
ﬂow cytometer equipped with 488 argon lasers (BD Bio-
sciences). For immunostaining, cells were washed and then
resuspended in 1 PBS containing 0.1% bovine serum albu-
min. Mouse Fc receptor was blocked before staining using
CD16/32 antibody to reduce nonspeciﬁc binding. After the
addition of antibodies, cells were incubated for 40 minutes on
ice; for peripheral blood, RBCs were further lysed using BD
FACS lysing solution (BD Biosciences). Labeled cells were
then washed with 1 PBS and were analyzed by ﬂow
cytometry. Appropriate isotype controls were kept for each set.
Forward and side scatter patterns were gated to exclude debris.
A total of 50,000 events were collected and analyzed using
FlowJo software version 7.6.5 (Tree Star Inc., Ashland, OR).
Erythroid lineage was assessed using Ter119 APC/CD71
phosphatidylethanolamine (PE) markers combined with the
forward scatter (FSC) properties.50 CXCR4 expression was
analyzed using PE-tagged CXCR4 antibody. Hematopoietic
stem/progenitor cells were differentiated using SLAMmarkers
(CD150 PE/CD48 APC), Sca1 ﬂuorescein isothiocyanate
(Ly6A-E), cKit Percp Cy5.5 (CD117), CD90 PE (Thy-1), and
APC-tagged lineage cocktail composed of antibodies against
CD3, B220 (CD45R), Ly6G and Ly6C (Gr1), CD11b (Mac1),
and TER-119. CKitþSca1þ cells were gated on the lineage-
negative fraction to analyze LSK (lincKitþSca1þ). The
LSK cells were then analyzed using a Thy-1low gate to obtain
the KTLS population (LSK Thylow). CD45.1 PE and CD45.2
ﬂuorescein isothiocyanate antibodieswere used to differentiate
donor and recipient populations after transplantation. All theThe American Journal of Pathology - ajp.amjpathol.organtibodies except the SLAMmarkers were purchased fromBD
Pharmingen (San Jose,CA). SLAMmarkersCD150 andCD48
were purchased from eBioscience Inc. (San Diego, CA).
Gene Expression Analysis
Total RNA from bone, BM, spleen, kidney, adult liver, and
fetal liver from 6-week-old or E15.5 wild-type (WT) and
Klotho/ mice was extracted using TRIzol reagent (Sigma-
Aldrich) according to the manufacturer’s protocol and was
quantiﬁed using a NanoDrop 2000 spectrophotometer
(Thermo Scientiﬁc). RNA (1 mg) from each sample was
reverse transcribed to cDNA in 10 mL of ﬁnal volume using a
high-capacity cDNA reverse transcription kit with random
hexamers (Applied Biosystems, Foster City, CA). Real-time
PCR analysis was performed using an Eppendorf Master-
cycler ep gradient S realplex2machine (Eppendorf, Hamburg,
Germany) in a ﬁnal reaction volume of 25 mL containing 1 mL
of the prepared cDNA of each gene, 12.5 mL of PerfeCTa
SYBR Green PCR SuperMix (Quanta BioSciences Inc.,
Gaithersburg, MD), and 1 mmol/L of primers amplifying the
genes of interest. Thermal cycle conditions were as follows:
60C for 2 minutes, 95C for 10 minutes, and 40 cycles at
95C for 15 seconds and 60C for 1 minute. Analyses were
performed in duplicate. Sampleswithout reverse transcriptase
were used as negative controls. The expression of klotho was
measured in BM, spleen, kidney, and fetal liver; the expres-
sion of Epo, Hif-1a, and Hif-2a was analyzed in bone, BM,
kidney, and liver; and the expression of transferrin, transferrin
receptor, glucose transporter type 1, and phosphoglycerate
kinase 1 was analyzed in BM and liver. All quantitative RT-
PCR values were normalized to the housekeeping gene
HPRT, and differences in gene expression between control
(WT) mice and Klotho/mice were calculated based on the
DCT method. The primer sequences are shown in Table 1.
ELISA
Serum Epo and stromal-derived factor-1a (SDF-1a) levels
were determined using Quantikine enzyme-linked immu-
nosorbent assay (ELISA) kits (R&D Systems, Minneapolis,
MN) according to the manufacturer’s instructions. Serum
samples were collected from 6-week-old WT and Klotho/
mice and were run in duplicate for each assay.
Colony-Forming Unit Assay
A colony-forming unit assay was performed for BM, spleen,
and fetal liver cells from 6-week-old or E15.5 WT and
Klotho/ mice. After isolation, the cells were incubated for
1 hour at 37C and 5% CO2 to allow for adherence to
eliminate major stromal cell fractions. BM or fetal liver cells
(1  104) and spleen cells (1  105) from the nonadherent
fraction were plated in methyl cellulose medium (MethoCult
M3231; STEMCELL Technologies Inc., Vancouver, BC,
Canada). Murine recombinant growth factors, including IL-3829
Table 1 Mouse Primer Sequences Used for Real-Time PCR Analysis
Gene Forward sequence Reverse sequence
Klotho 50-ACTTGGCCTTTATTAGCCGGGTCT-30 50-AGATGGCCTCTTCCCTGTGTTCAA-30
Erythropoietin (Epo) 50-TCTACGTAGCCTCACTTCACT-30 50-ACCCGGAAGAGCTTGCAGAAA-30
Hypoxia-inducible factor-1a (HIF-1a) 50-TCTCGGCGAAGCAAAGAGTCT-30 50-TAGACCACCGGCATCCAGAAG-30
Hypoxia-inducible factor-2a (HIF-2a) 50-GGGAACACTACACCCAGTGC-30 50-TCTTCAAGGGATTCTCCAAGG-30
Transferrin 50-CCCTCTGTGACCTGTGTATTG-30 50-CTTTCTCAACGAGACACCTGAA-30
Transferrin receptor 50-TCCTGTCGCCCTATGTATCT-30 50-CGAAGCTTCAAGTTCTCCACTA-30
Glucose transporter-1 (Glut-1) 50-CCCAGGTGTTTGGCTTAGA-30 50-CAGAAGGGCAACAGGATACA-30
Phosphoglycerate kinase-1 (Pgk-1) 50-CACAGAAGGCTGGTGGATTT-30 50-CTTTAGCGCCTCCCAAGATAG-30
HPRT 50-AAGCCTAAGATGAGCGCAAG-30 50-TTACTAGGCAGATGGCCACA-30
Vadakke Madathil et al(4 ng/mL), stem cell factor (20 ng/mL), granulocyte macro-
phage colony-stimulating factor (2 ng/mL), and Epo (2U/mL)
(PeproTech, Rocky Hill, NJ), were added to the medium. The
plates were incubated in humidiﬁed atmosphere at 37C and
5% CO2. After incubation (8 to 12 days), the colonies were
scored based onmorphology as burst-forminguniteerythroid)
or granulocyte-erythroid-megakaryocyte-macrophage under a
Nikon TMS inverted phase contrast microscope (Nikon In-
struments, Melville, NY).
Transwell Migration Assay
Chemotactic responses of the WT and Klotho/ BM cells
to SDF-1a were assessed in vitro by Transwell migration
assay. Brieﬂy, 105 BM cells from 6-week-old WT and
Klotho/ mice were seeded to the upper chamber of the
8-mm BD Falcon 24-well cell culture insert (BD Biosciences).
One hundred nanograms of SDF-1a (PeproTech) was added
to the lower wells, containing 600 mL of medium. For each
experiment, some wells were kept in both sets without SDF-
1a to detect spontaneous migration. The cells were allowed
to migrate for 3 hours at 37C and 5% CO2. The migrated
cells were collected and manually counted. The percentage
of migration was calculated as follows: (total number of
input cells/number of cells migrated)  100.
In Vivo Homing Experiments
BM cells (2  106 cells suspended in 1 PBS) from 6-week-
oldWTandKlotho/mice (CD45.2;Ly5.2)were isolated and
injected into the tail vein of nonmyeloablated or myeloablated
B6.SJL (CD45.1; Ly5.1) recipient mice (nZ 5 per set for each
experiment). Myeloablation was achieved by a lethal dose of
irradiation (900 rads). Twenty hours after transplantation, pe-
ripheral blood, spleen, and BM were collected from recipient
mice and were analyzed for the presence of CD45.2þ donor
cells by ﬂow cytometry. A minimum of 50,000 events were
acquired using a BD FACSort ﬂow cytometer equipped with
488 argon lasers (BD Biosciences).
Klotho Protein Injections
Mouse recombinant klotho protein (10 mg/kg) (R&D Sys-
tems) was injected i.p. into 8-week-old C57/Bl/6 mice every830other day for 3 days. Saline (1 PBS) was injected as
vehicle. Peripheral blood, spleen, and BM cells were immu-
nostained for erythroid and hematopoietic stem/progenitor
markers and were analyzed by ﬂow cytometry as described
previously herein.
Statistical Analysis
Statistical differences between groups were analyzed by un-
paired Student’s t-test. More than six mice were analyzed for
each set per experiment, and all the values are expressed as
means  SEM. Graphs were plotted using GraphPad Prism
software version 5.0 (GraphPad Software Inc., San Diego,
CA). A P  0.05 was considered statistically signiﬁcant.
Results
Klotho Expression in Hematopoietic Tissues
Klotho is predominantly expressed in the renal distal tubular
epithelial cells and, to a lesser extent, in a variety of other
tissues, such as the parathyroid gland, choroid plexus in the
brain, placenta, and small intestine.6,51e53 To dissect the
role of klotho in hematopoiesis, we examined whether
klotho transcripts are expressed in hematopoietic tissues.
We analyzed klotho expression in total BM cells and sple-
nocytes from 6-week-old WT mice and in fetal liver cells
from E15.5 WT embryos by real-time PCR. Adult mouse
kidney cells were used as a positive control. As expected,
klotho was highly expressed in kidney, which is the primary
source of klotho production. These results showed that
klotho mRNA is also expressed in BM, spleen, and fetal
liver cells, albeit at much lower levels than in kidney,
suggesting a possible role for klotho signaling in hemato-
poiesis. The real-time data are expressed as fold change with
respect to the housekeeping gene HPRT (Supplemental
Figure S1A).
Hematologic Phenotype of Klotho/ Mice
To assess the effect of klotho in steady-state hematopoiesis,
we compared the hematopoietic output of 6-week-old
Klotho/ mice with that of their WT and Klothoþ/ (het-
erozygous) littermates. Complete blood cell count analysisajp.amjpathol.org - The American Journal of Pathology
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levels, and hematocrit values in Klotho/ mice (Figure 1,
AeC). Conversely, a signiﬁcant decrease in RBC indices,
such as mean corpuscular volume (MCV) and mean
corpuscular hemoglobin (MCH), was detected in peripheral
blood of Klotho/ mice (Figure 1, D and E). No differ-
ences were found in any of the examined hematologic pa-
rameters between WT and Klothoþ/ (heterozygous) mice.
Loss of Klotho Results in Increased BM Erythropoiesis
without Extramedullary Erythropoiesis
We further examined the effect of klotho deﬁciency in
erythroid cell production and differentiation in BM as the
origin of hematopoiesis in adult mice. Total BM cellularity
was modestly decreased in Klotho/ mice compared with
WT littermates (data not shown). Successive stages of
erythroid commitment were determined based on cell size
(FSC) coupled with expression of Ter119 and the transferrin
receptor CD71. We observed a signiﬁcant increase in
immature pro-erythroblasts (Pro-E) (Ter119med CD71high) in
the BM of Klotho/ mice (Figure 2A). Further analysis
based on cell size showed that the absence of klotho resulted
in a marked increase in the relatively mature erythroid C
(Ery-C) fraction (Ter119highCD71lowFSClow) of erythro-
blasts in comparison to WT littermates (Figure 2B). How-
ever, there were no discernible changes in the intermediate
Ery-A (Ter119highCD71high FSChigh) and Ery-B (Ter119-
highCD71medFSClow) populations (Supplemental Figure S1,
B and C). In addition, an in vitro colony-forming unit assay
showed that Klotho/ BM cells generated more erythroid
colonies (burst-forming uniteerythroid) than WT cells,
indicating the presence of increased functional erythroid
progenitors in Klotho/ BM (Figure 2C).Figure 1 Complete blood cell count analysis of 6-week-old WT, heterozygous
nZ 23; þ/, nZ 8; /, nZ 18). B: Hemoglobin levels (WT, nZ 19; þ/,
/, nZ 16). D: MCV (WT, nZ 21; þ/, nZ 10; /, nZ 20). E: MCH (WT,
*P < 0.05, **P < 0.01, and ****P < 0.0001.
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erythropoiesis in stress and inﬂammation, we next analyzed
splenic erythropoiesis. Klotho mutant mice developed
postnatal growth retardation and early mortality, with most
Klotho/ mice dying by 9 weeks after birth.6 Klotho/
mice were signiﬁcantly smaller than their control litter-
mates, and their spleen size was also found to be markedly
decreased. However, even when the spleen size was cor-
rected to body weight, the ratio of Klotho/ spleen weight
to body weight was one-third that of their WT littermates
(Supplemental Figure S1D). In addition, total spleen cellu-
larity was also decreased in Klotho/ mice compared with
their WT littermates (Supplemental Figure S1E). Although
there were no remarkable changes in primitive erythroid
lineage cells in the spleens of Klotho/ mice (data not
shown), we observed a signiﬁcant decrease in the mature
Ery-C (Ter119highCD71lowFSClow) fraction of the erythroid
population (Figure 2D) accompanied by a decrease in the
number of burst-forming uniteerythroid colonies generated
by Klotho/ splenocytes (Figure 2E). These data suggested
a decline in splenic erythropoiesis and rules out the possi-
bility of extramedullary hematopoiesis in the absence of
klotho.
Enhanced Erythropoiesis in Klotho/ Mice Is
Mediated through Epo and the HIF Signaling Pathway
BM erythropoiesis is under the tight control of Epo secreted
from the kidneys. Therefore, we examined whether enhanced
erythropoiesis inKlotho/mice is Epomediated.EpomRNA
expression was signiﬁcantly up-regulated in Klotho/ kid-
ney, BM, and liver cells (Figure 3, AeC). Similarly, serum
Epo levels were signiﬁcantly elevated in klotho/ mice
compared with their WT littermates, indicating enhanced Epo(Klothoþ/), and KlothoKlotho-null (Klotho/) mice. A: RBC counts (WT,
nZ 9; /, nZ 16). C: Hematocrit values (WT, nZ 19; þ/, nZ 10;
nZ 16; þ/, nZ 10; /, nZ 16). Data represent the means  SEM.
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Figure 2 BM and splenic erythropoiesis in 6-week-old WT and Klotho/ mice. A: Flow cytometry analysis shows an increase in primitive Pro-Es (Ter119med
CD71high) in Klotho/ mice (Pro-E: WT, nZ 12; Klotho/, nZ 9); inset shows ﬂow cytometry gating. B: Erythroid lineage commitment was analyzed using
Ter119 and CD71 markers coupled with FSC measurements. A mature Ery-C (Ter119high CD71low FSClow) population was observed in Klotho/ compared with WT
littermates (Ery-C: WT, n Z 9; Klotho/, n Z 7); inset shows ﬂow cytometry gating on the Ter119high population. C: Colony-forming unit assay showing
burst-forming uniteerythroid (BFU-E) colonies produced by Klotho/ BM cells (WT, n Z 13; Klotho/, n Z 11). Cells from each mouse were plated in
triplicate, and the number of colonies was scored based on morphologic features. D: Graphic representation of ﬂow cytometry analysis of the mature Ery-C
population in Klotho/ splenocytes (WT, n Z 9; Klotho/, n Z 8). E: Colony-forming unit assay showing splenic BFU-E colonies in Klotho/ mice (WT,
n Z 4; Klotho/, n Z 4). Cells from WT and Klotho/ spleens were plated in triplicate. Data represent the means  SEM. *P < 0.05 and **P < 0.01.
Vadakke Madathil et alsecretion in the absence of klotho (Figure 3D). Previous
studies have demonstrated that the aging kidney is exposed to
hypoxia, to which it responds by activation of HIF signaling
andup-regulation ofHIF-regulated genes.54BecauseKlotho/
mice present with aging-like features and Epo is an HIF target
gene, we next examined HIF-1a and HIF-2a expression inWT
and Klotho/ kidneys. Renal mRNA expression of HIF-1a
(Supplemental Figure S1F) and HIF-2a (Figure 3E) was simi-
larly up-regulated inKlotho/mice, consistent with the notion
that activation of HIF by hypoxia results in increased Epo
production. Although the kidney was the major Epo-producing
organ, it has been reported that in some pathologic conditions,
hepaticEpoproduction is increased.55Therefore,we studied the
expression of important HIF target genes in the liver and BM of
WT and Klotho/ littermates. The expression of glucose
transporter type 1, phosphoglycerate kinase 1, transferrin, and
transferrin receptor was signiﬁcantly up-regulated in the liver
and BM in Klotho/ mice (Figure 3, FeK), conﬁrming acti-
vation of the HIF pathway and erythropoiesis. These ﬁndings
suggest that enhanced erythropoiesis in Klotho/ mice is Epo
induced and is driven by augmented HIF signaling and may
serve as a mechanism to respond to stress conditions, such as
anemia and inﬂammation.
Absence of Klotho Results in Altered Localization of
Hematopoietic Stem/Progenitor Cells
To investigate whether increased erythropoiesis in Klotho/
mice is due to expansion of the HSC compartment and/or832increased differentiation of progenitor cells, we analyzed by
ﬂow cytometry the frequency of HSCs in BM, peripheral
blood, and spleen. These data show a signiﬁcant decrease in the
CD150þCD48 (SLAM) population highly enriched in HSCs
and in the frequency of the LincKitþSca-1þ (LSK) and the
more primitive cKitþ Thy-1low Lin Sca1þ (KTLS) fraction in
the BM of Klotho/ mice compared with WT littermates
(Figure 4, AeC). These ﬁndings suggest that loss of klotho
results in an overall reduction in the HSC pool size in the BM
possibly due to an increase in differentiation of HSCs to the
erythroid lineage. We observed an increase in the circulating
progenitors marked by SLAM (CD150þCD48) markers in
Klotho/ mice (Figure 4D). Moreover, we observed an in-
crease in the phenotypic HSCs in Klotho/ spleens as
detected by elevated SLAM (CD150þCD48) (Figure 4E),
LSK (LinSca-1þcKitþ) (Figure 4F), and the most primitive
KTLS (cKitþ Thy-1low Lin Sca-1þ) (Figure 4G) hemato-
poietic stem/progenitor cells. The increase in circulating and
splenic HSCs in Klotho/ mice suggested a possible homing
defect during development. Collectively, these observations
indicate that the hematopoieticmilieu ofmice lackingKlotho is
severely disturbed compared with control WT littermates.
Migratory Properties of BM Cells from Klotho/ Mice
Are Severely Impaired, Resulting in Disrupted Homing
in Vivo
The present peripheral blood, BM, and spleen data
demonstrated that loss of klotho results in highly perturbedajp.amjpathol.org - The American Journal of Pathology
Figure 3 Increased erythropoiesis by activation of HIF signaling and up-regulation of HIF target genes in 6-week-old klotho/ mice. Real-time quan-
titative PCR of renal Epo mRNA (WT, n Z 5; Klotho/, n Z 5) (A), BM Epo mRNA (WT, n Z 14; Klotho/, n Z 6) (B), and liver Epo mRNA (WT, n Z 9;
Klotho/, n Z 7) (C). D: Serum Epo levels (WT, n Z 14; Klotho/, n Z 14). E: Real-time quantitative PCR of HIF-2a in kidney (WT, n Z 6; Klotho/,
nZ 5), liver (WT, nZ 5; Klotho/, nZ 4), and BM (WT, nZ 6; Klotho/, nZ 4). F: Liver transferrin (WT, nZ 5; Klotho/, nZ 6). G: Liver transferrin
receptor (WT, nZ 6; Klotho/, nZ 6). H: Liver glucose transporter type 1 (glut-1) (WT, nZ 6; Klotho/, nZ 6). I: BM transferrin (WT, nZ 6; Klotho/,
n Z 4). J: BM glut-1 (WT, n Z 6; Klotho/, n Z 4). K: BM phosphoglycerate kinase 1 (pgk-1) (WT, n Z 6; Klotho/, n Z 4). Data represent the
means  SEM, normalized to HPRT and plotted as fold change over WT (where WT Z 1). *P < 0.05, **P < 0.01, and ***P < 0.001.
Klotho Regulates Hematopoiesiserythropoiesis and suggest that this may be related to altered
homing or retention of hematopoietic stem/progenitor cells
in the Klotho-deﬁcient BM. The homing mechanism is
dependent on expression of the chemokine SDF-1a/CXCL-
12 and other cell adhesion molecules and extracellularFigure 4 Altered localization of hematopoietic stem/progenitor cells in Klot
CD48) (WT, n Z 14; Klotho/, n Z 14) (A), the Lin Sca-1þ (C) Kitþ (LSK
c-KitþThy1þLinSca 1þ (KTLS) HSC population (WT, n Z 7; Klotho/, n Z 7) (C
population in peripheral blood (PB) (WT, nZ 7; Klotho/, nZ 6). Retention of
(LSK) (WT, nZ 9; Klotho/, nZ 9) (F), and primitive c-KitþThy1þLinSca 1þ (
Klotho/ mice compared with their WT littermates. Data represent the means 
The American Journal of Pathology - ajp.amjpathol.orgmatrix proteins that guide the hematopoietic stem/progenitor
cells to the niche. To address the hypothesis, we performed
an in vitro Transwell migration assay that compared the
migratory function of BM cells from WT and Klotho/
mice toward SDF-1a. The ﬁndings showed that BM cellsho/ mice. Frequency of the HSC population stained for SLAM (CD150þ
) HSC population (WT, n Z 9; Klotho/, n Z 7) (B), and the primitive
) in the Klotho/ BM compartment. D: Circulating SLAM (CD150þ CD48)
phenotypic SLAM (WT, nZ 11; Klotho/, nZ 8) (E), Lin Sca-1þ c-Kitþ
KTLS) population (WT, nZ 10; Klotho/, nZ 9) (G) in splenocytes from
SEM. *P < 0.05 and **P < 0.01.
833
Vadakke Madathil et alfrom Klotho-deﬁcient mice exhibited a twofold decrease in
chemotaxis toward an SDF-1a gradient compared with WT
mice (Figure 5A). Spontaneous migration in the absence of
SDF-1a was also assessed simultaneously and was found to
be low, with no difference between WT and Klotho/
mice. Furthermore, we analyzed the expression of CXCR4,
the putative receptor for SDF-1a, and found that the reduced
chemotactic response of Klotho/ BM cells was associated
with a decrease in overall CXCR4þ population in Klotho/
BM (Figure 5B). These ﬁndings were conﬁrmed by quanti-
fying serum levels of SDF-1a in WT and Klotho/ mice.
SDF-1a levels were found to be signiﬁcantly reduced in mice
lacking Klotho, indicating that trafﬁcking of stem/progenitor
cells between peripheral blood and the BM compartment is
impaired (Figure 5C). These results were further conﬁrmed
by an in vivo assay in which we compared the direct and
competitive steady-state homing potential of BM cells from
WT and Klotho/ mice. Studies have shown that lethal
irradiation creates a noncompetitive host HSC pool that can
be easily replaced by donor HSCs, whereas a non-
myeloablated environment may better portray natural traf-
ﬁcking patterns of HSCs in vivo and allow greater recovery
and better survival of donor cells.56e58 Therefore, we trans-
plantedKlotho/ orWTBM cells into nonmyeloablated and
myeloablated B6.SJL WT recipient mice and assessed their
direct homing efﬁciency 20 hours after transplantation. We
found a marked reduction in the ability of Klotho/ cells to
lodge in a normal BMmicroenvironment (Figure 5, D and G,
and Supplemental Figure S2, C and D) compared with
transplanted WT BM cells. Furthermore, these experiments
showed that most transplanted Klotho/ BM cells were
localized in the peripheral blood (Figure 5, D and E, and
Supplemental Figure S2, A and D). However, localization of
Klotho/ and WT transplanted BM cells was similar in theFigure 5 The perturbed in vitro and in vivo homing ability of Klotho/ BM ce
BM cells toward an SDF-1a gradient (WT, n Z 5; Klotho/, n Z 5). B: Flow cy
Klotho/, n Z 8). C: SDF-1a concentration measured by ELISA in the serum o
duplicate. D: Graphic representation of ﬂow cytometry analysis of the BM, splee
(nZ 8) BM cells in myeloablated B6.SJL recipient mice. EeG: Flow cytometry pro
scatter. Data represent the means  SEM. *P < 0.05 and **P < 0.01.
834spleens of nonmyeloablated and myeloablated recipient mice
(Figure 5, D and F, and Supplemental Figure S2, B and D).
Together, these results conﬁrm a defect in the homing ability
of Klotho/ BM cells and clearly demonstrate that lack of
klotho results in impaired lodgment and retention of BM cells
in a normal microenvironment owing to a defect in their
migratory function.
Increased Vitamin D Levels Are Only Partially
Responsible for the Hematopoietic Changes in
Klotho/ Mice
Because Klotho/ mice exhibit highly elevated vitamin D
levels and vitaminD is known to regulate physiologic functions
of klotho,59 we investigated whether elimination of vitamin D
activity can rescue the hematopoietic changes observed in
Klotho/mice.We generated compoundmutantmice lacking
both Klotho and 1a(OH)ase, the enzyme responsible for con-
verting vitaminD to its active form.Acomplete bloodcell count
analysis was performed in WT, Klotho//1a(OH)aseþ/þ,
Klotho//1a(OH)ase/, and Klothoþ/þ/1a(OH)ase/ lit-
termates. As shown in Figure 6A, although Klotho//1a(OH)
ase/ double-mutantmice still displayed an increased number
of circulating RBCs, genetic ablation of 1a(OH)ase from
Klotho/mice restored theMCVandMCH tonormal levels in
the double mutants (Figure 6, B and C).
However, ﬂow cytometry analysis of erythroid populations
in the BM showed that the frequency of immature erythroid
population (Pro-E; pro-erythroid) and the more mature Ery-C
fraction was similarly increased in Klotho/ and Klotho/
/1a(OH)ase/ double-mutantmice but not in 1a(OH)ase/
mice (Figure 6, D and E). Similarly, circulating Epo levels
were highly elevated in Klotho/ and Klotho//1a(OH)
ase/ mutant mice compared with WT and 1a(OH)ase/lls. A: In vitro migration experiment of the migratory capacity of Klotho/
tometry of CXCR4 in Klotho/ BM compared with WT mice (WT, n Z 11;
f WT (n Z 10) and Klotho/ (n Z 10) mice. Samples were measured in
n, and peripheral blood after transplantation of WT (n Z 8) or Klotho/
ﬁles of the peripheral blood, spleen, and BM after transplantation. SSC, side
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Figure 6 Genetic ablation of 1a(OH)ase partially rescued hematopoietic changes in Klotho/ mice. AeC: Complete blood cell count analysis of WT,
Klotho//1a(OH)aseþ/þ, Klotho//1a(OH)ase/, and Klothoþ/þ/1a(OH)ase/ mice. RBC counts [WT, n Z 14; Klotho//1a(OH)aseþ/þ, n Z 11;
Klotho//1a(OH)ase/, nZ 16; Klothoþ/þ/1a(OH)ase/, nZ 11] (A), MCV [WT, nZ 12; Klotho//1a(OH)aseþ/þ, nZ 13; Klotho//1a(OH)ase/,
nZ 15; Klothoþ/þ/1a(OH)ase/, nZ 15] (B), and MCH [WT, nZ 17, klotho//1a(OH)aseþ/þ, nZ 12; Klotho//1a(OH)ase/, nZ 17; Klothoþ/þ/
1a(OH)ase/, nZ 17] (C). DeF: Flow cytometry analysis of BM cells from all four genotypes. Percentage of the Pro-E population [WT, nZ 16; Klotho//
1a(OH)aseþ/þ, nZ 14; Klotho//1a(OH)ase/, nZ 12; Klothoþ/þ/1a(OH)ase/, nZ 13] (D) and the Ery-C population [WT, nZ 13; Klotho//1a(OH)
aseþ/þ, n Z 10; Klotho//1a(OH)ase/, n Z 9; Klothoþ/þ/1a(OH)ase/, n Z 12] (E) and serum Epo levels [WT, n Z 9, Klotho//1a(OH)aseþ/þ,
n Z 6; Klotho//1a(OH)ase/, n Z 9, Klothoþ/þ/1a(OH)ase/, n Z 7] (F). G: Percentage of LSK progenitors [WT, n Z 7; Klotho//1a(OH)aseþ/þ,
n Z 7; Klotho//1a(OH)ase/, n Z 7; Klothoþ/þ/1a(OH)ase/, n Z 7]. Data represent the means  SEM. *P < 0.05, **P < 0.01, and ***P < 0.001
versus WT; yP < 0.05, yyP < 0.01 versus Klotho//1a(OH)aseþ/þ; zP < 0.05 versus Klotho//1a(OH)ase/.
Klotho Regulates Hematopoiesismice (Figure 6F). Erythropoiesis seemed to be unaffected in
1a(OH)ase/ mice, as indicated by the examined parame-
ters. Therefore, these data suggest that the increase in eryth-
ropoiesis in the absence of klotho is independent of vitamin D
levels and is most likely associated with loss of klotho func-
tion. There was no difference in the frequency of hemato-
poietic progenitor cells (LSK; LinSca-1þcKitþ) amongWT,
Klotho//1a(OH)ase/ double mutants, and 1a(OH)
ase/ mice, in contrast to decreased LSK frequency in
Klotho/mice (Figure 6G), suggesting that excess vitaminD
negatively affects hematopoietic progenitor numbers. Taken
together, these ﬁndings suggest that elimination of vitamin D
could not completely rescue the hematopoietic abnormalities
observed in Klotho/ mice, signifying the importance of
klotho in the regulation of hematopoiesis.
Klotho Protein Administration Inﬂuences Steady-State
Hematopoiesis in Vivo
These ﬁndings so far clearly reveal that lack of klotho
adversely affects hematopoiesis. To determine whether the
effect of klotho is direct, we investigated whether exogenous
administration of klotho protein can modulate steady-stateThe American Journal of Pathology - ajp.amjpathol.orghematopoiesis. Intraperitoneal injection of klotho protein in 8-
week-old WT mice resulted in differential regulation of HSCs
in various tissues analyzed. Flow cytometry analysis showed a
decrease in erythroid progenitors in peripheral blood and BM
(Figure 7, AeD), followed by augmented splenic erythro-
poiesis (Figure 7, E and F) in klotho-injected mice compared
with vehicle-injected mice. Moreover, administration of klo-
tho protein resulted in higher LSK (LinSca-1þcKitþ) he-
matopoietic stem/progenitor cell levels (Figure 7G) in BM and
more progenitor cell (granulocyte-erythroid-megakaryocytee
macrophage) colonies in vitro (Figure 7H). These data show
that klotho administration results in hematopoietic changes
opposite to the ones observed in klotho-deﬁcient mice. Taken
together, these results clearly demonstrate a novel role for
klotho in the regulation of steady-state hematopoiesis. How-
ever, the exact mechanism of the differential modulation of
hematopoiesis requires further investigation.
Klotho Deﬁciency Results in Disrupted Hematopoiesis
Independent of the BM Microenvironment
The BM hematopoietic changes observed postnatally in
Klotho-deﬁcient mice could be associated with the dramatic835
Figure 7 Klotho protein injection inﬂuenced hematopoiesis in WT mice. AeG: Flow cytometry analysis of erythroid populations in peripheral blood (PB)
and BM and of erythroid cells in spleen. Peripheral blood: Percentage of the Pro-E population [WT (þ vehicle), nZ 3; WT (þ Klotho), nZ 10] (A) and the Ery-
C population [WT (þ vehicle), nZ 6; WT (þ klotho), nZ 7] (B). BM: Percentage of the Ery-A population [WT (þ vehicle), nZ 5; WT (þ klotho), nZ 9] (C)
and the Ery-C population [WT (þ vehicle), n Z 5; WT (þ klotho), n Z 8] (D). Spleen: Percentage of the Ery-A population [WT (þ vehicle), n Z 7; WT (þ
klotho), nZ 8] (E) and the Ery-B population [WT (þ vehicle), nZ 7; WT (þ klotho), nZ 7] (F). G: Percentage of LSK (lin Sca-1þ c-Kitþ) progenitors in the
BM of injected mice [WT (þ vehicle), nZ 8; WT (þ klotho), nZ 6]. H: Colony-forming unit assay of BM granulocyte-erythroid-megakaryocyte-macrophage
(GEMM) mix colonies in klotho-injected mice [WT (þ vehicle), nZ 8; WT (þ klotho), nZ 10]. Data represent the means  SEM. *P < 0.05, ****P < 0.0001.
Vadakke Madathil et alreduction in osteoblast and osteoclast numbers and bone
mineral density in Klotho/ bones. However, the decrease
in HSCs in Klotho/ BM and their retention in the spleen
along with the defect in their homing ability (as seen in vitro
and in vivo) suggest that klotho deﬁciency impairs hema-
topoiesis regardless of the BM microenvironment. To
address this hypothesis, we studied prenatal hematopoiesis
in Klotho/ mice. Because embryonic hematopoiesis in
fetal liver declines after E15.5, we isolated fetal liver cells
from time pregnant female mice on E15.5 and studied
changes in fetal liver hematopoiesis. The yield of fetal liver
cells from Klotho/ mice was signiﬁcantly lower compared
with WT littermates (Supplemental Figure S2E). We found
that fetal liver hematopoiesis in Klotho/ mice was simi-
larly affected, with changes similar to those detected in the
BM compartment of adult Klotho/ mice. Analysis of the
erythroid population showed an increase in early erythroid
cells (Pro-E; Ter119medCD71high) (Figure 8A) and in the
more mature Ery-C fraction (Ter119highCD71lowFSClow)
(Figure 8B) of erythroblasts in Klotho/ fetal liver cells, a
ﬁnding supported by enhanced erythroid colony-forming836ability in vitro (Figure 8C). More importantly, we
observed a marked reduction in LinSca1þcKitþ (LSK) and
cKitþ Thy-1low Lin Sca-1þ (KTLS) HSCs in Klotho/
fetal liver cells compared with WT fetal livers (Figure 8, D
and E). This was concomitant with a signiﬁcant decrease in
the ability of Klotho/ fetal liver cells to form granulocyte-
erythroid-megakaryocyteemacrophage colonies in vitro
(Figure 8F). These data indicate a global defect in the HSC
turnover in the absence of klotho. This novel observation,
that klotho deﬁciency affects prenatal hematopoiesis, clearly
demonstrates a potential role for the antiaging hormone
klotho in hematopoietic development.Discussion
Several lines of evidence suggest that aging has a major
effect on HSC function and localization.60e66 Klotho has
previously been identiﬁed as an aging-suppressor gene that
has an active role in the renal control of calcium, phosphate,
and vitamin D metabolism, and Klotho gene deﬁciency isajp.amjpathol.org - The American Journal of Pathology
Figure 8 Klotho deﬁciency affected fetal liver (FL) hematopoietic milieu. Flow cytometry analysis of E15.5 FL cells. Immature erythroid cells (Pro-E;
Ter119medCD71high) (WT, nZ 9; Klotho/, nZ 10) (A) and Ery-C fraction (Ter119high CD71low FSClow) (WT, nZ 8; Klotho/, nZ 6) (B) in Klotho/ FLs. C:
Colony-forming unit assay of burst-forming uniteerythroid (BFU-E) colonies produced by Klotho/ FL cells (WT, nZ 7; Klotho/, nZ 9). Cells from each
mouse were plated in triplicate, and the number of colonies in each plate was counted. Frequency of Lin Sca-1þ c-Kitþ (LSK) (WT, nZ 10; Klotho/, nZ 8)
(D) and c-KitþThy1þLinSca-1þ (KTLS) (WT, n Z 7; Klotho/, n Z 8) (E) HSC populations in Klotho/ FLs. F: Colony-forming unit assay of primitive
granulocyte-erythroid-megakaryocyte-macrophage (GEMM) colonies in Klotho/ FL cells (WT, nZ 7; Klotho/, nZ 9). Cells from each mouse were plated in
triplicate, and the number of colonies in each plate was counted. Data represent the means  SEM. *P < 0.05, ***P < 0.001.
Klotho Regulates Hematopoiesisassociated with renal and skeletal abnormalities, including
low-bone-turnover osteopenia characterized by a decreased
bone formation rate, reduced osteoblast and osteoclast
numbers, and severely impaired bonemineral density.26,67e69
Defects in bone ossiﬁcation and altered mineral ion meta-
bolism have adverse effects in the BMmicroenvironment that
houses the hematopoietic stem and progenitor cells.38,70
Several studies have reported that decreased osteoblast and
osteoclast numbers and bonemineral content result in reduced
B-lymphocyte and HSC numbers.37e39,44,45,71e74 In addi-
tion, defective endochondral ossiﬁcation causes aberrant B
lymphopoiesis in mice.75,76 The present study is the ﬁrst to
demonstrate that normal function of klotho is required for
balanced erythropoiesis and to establish a novel role for
klotho in the regulation of RBC formation.We show thatmice
deﬁcient in Klotho exhibit perturbed prenatal and postnatal
hematopoiesis and, hence, are incapable of sustaining a
balanced hematopoietic milieu.
Klotho deﬁciency is a characteristic feature of CKD in
which anemia and vascular calciﬁcations are prevalent.
Moreover, kidney disease is associated with inﬂammation
and aging. Direct involvement of klotho in vascular calci-
ﬁcations was demonstrated in recent studies.17,18 Therefore,
understanding the extrarenal functions of klotho is of great
clinical signiﬁcance for therapeutic intervention in patho-
logic conditions associated with CKD and CVD. This study
shows that loss of klotho in mice results in reduced MCV
and MCH in circulating RBCs. Erythropoiesis is tightly
regulated between the kidney and BM microenvironment by
the production of Epo, a hormone secreted by the kidneyThe American Journal of Pathology - ajp.amjpathol.organd acting on the erythroid progenitors in the BM. BM
erythropoiesis is a complex and dynamic process that in-
volves proliferation of immature erythroblasts and matura-
tion through successive stages, leading to enucleation of
mature erythrocytes. As a response to inherited or acquired
anemia, the kidneys produce Epo to increase RBC produc-
tion and oxygenation. Hypoxia acts as a physiologic stim-
ulus to induce Epo transcription.77,78 Studies have shown
that administration of recombinant Epo can induce klotho
expression in a rat nephropathy model, suggesting that these
kidney-derived proteins can interact in vivo.79 Herein we
demonstrate that despite the low MCV and MCH, klotho
deﬁciency in mice results in increased erythropoiesis
through activation of the HIF signaling pathway and sub-
sequent increased Epo secretion and up-regulation of renal
Epo mRNA. Although the kidney is the primary site for Epo
production in adult animals, other tissues also produce Epo. It
has been recently reported that osteoblasts can also produce
Epo through activation of the HIF pathway under physiologic
and pathophysiologic conditions.80 In the present studies, we
found that the expression of HIF-1a and HIF-2a was
signiﬁcantly attenuated in Klotho/ bone, resulting in local
suppression of Epo (unpublished data, S.V.M., L.M.C., C.C.,
D.S.). These ﬁndings suggest that reduced osteoblast
numbers and osteopenia in Klotho/ mice may be respon-
sible for the inhibition of HIF and Epo in bone and further
support the hypothesis for tissue-speciﬁc hypoxic induction
of Epo, leading to increased erythrocyte production.
We found that klotho deﬁciency results in decreased
frequency of LincKitþSca1þ (LSK) and cKitþ Thy-1low837
Vadakke Madathil et alLin Sca-1þ (KTLS) HSCs in the BM and fetal liver.
However, HSC numbers were increased in the blood and
spleen of Klotho/ mice, suggesting that in the absence of
klotho, primitive HSC populations reside in sites other than
the BM. These observations raised the possibility that the
decrease in BM HSC numbers may be due to altered
homing or retention of the cells in the correct microenvi-
ronment. Retention and homing of HSCs to the BM depends
on the presence of chemokines, extracellular matrix pro-
teins, and osteoblasts. The present data show that Klotho
deletion results in a decreased response of BM cells to a
gradient of SDF-1a, low serum SDF-1a, and reduced
CXCR4þ cells in the BM, suggesting that the Klotho/ BM
stroma does not support HSC retention, and that the migra-
tory function of Klotho/ BM cells is impaired. Further-
more, in vivo homing assays conﬁrmed these observations
and demonstrated that transplanted Klotho/ BM cells were
unable to competently lodge in a normal BM microenvi-
ronment regardless of whether there was competition (non-
myeloablation) or not (myeloablation). Also, trafﬁcking from
the marrow to the periphery was increased in klotho deﬁ-
ciency. The present ﬁndings, together with the current un-
derstanding that loss of osteoblasts negatively regulates the
size of the HSC niche and results in defective HSC local-
ization,37e39,45,81 suggest that i) impaired bone mineraliza-
tion and loss of osteoblasts and osteoclasts inKlotho/mice
may alter the BM microenvironment, rendering it non-
conducive to supporting normal hematopoiesis, ii) the
decrease in HSC numbers in Klotho/ mice may be due to
an accelerated differentiation of these cells toward the
erythroid lineage, and/or iii) the abnormalities found in
Klotho/ HSCs may be due to a cell-autonomous defect in
their ability to engage the niche in vivo. Preliminary data from
the Despina Sitara Laboratory (Department of Basic Science
and Craniofacial Biology New York University College
of Dentistry, and Department of Medicine New York Uni-
versity School of Medicine, NY) show that after long-term
competitive repopulation transplantations, Klotho/ BM
cells do not engraft as competently as WT BM cells to the
BM environment of lethally irradiated WT mice (unpub-
lished data, S.V.M., L.M.C., C.C., D.S.). These ﬁndings
suggest that Klotho deletion results in an intrinsic abnor-
mality of the HSCs to efﬁciently engraft to a normal BM
niche and that HSCs do not depend on the Klotho/ host
BM environment. More transplantation studies are currently
under way to conﬁrm these observations.
Previously published data show that Klotho-null mice
exhibit B lymphopenia and low levels of IL-7, which is
essential for early B-cell development in the BM, and they
attribute these changes to aging.32 Klotho mRNA expression
has also been found to be signiﬁcantly decreased in resting
human CD4þ lymphocytes proportionally to advancing
age.33 Additionally, a shift toward myeloid lineage commit-
ment and reduced B lymphopoiesis are well-documented
phenomena in both murine and human aging.65,82,83 Taken
together, the effect of klotho deﬁciency in lymphopoiesis and838myelopoiesis and the mechanisms mediating these effects
require further investigation.
Lack of klotho disturbs mineral ion homeostasis and
vitamin D balance, leading to hyperphosphatemia, hypercal-
cemia, and hypervitaminosis D. Previous studies convinc-
ingly demonstrated that genetic ablation of vitamin D can
reverse phosphate and calcium excess and rescue aging and
growth retardation in Klotho/ mice.59,84 In addition, the
vitamin D receptor is known to play an important role in he-
matopoiesis.46 Therefore, we investigated whether the
mechanism of altered hematopoiesis in Klotho/ mice is
vitamin D mediated. We observed that the altered erythro-
poiesis in Klotho/mice could not be completely rescued in
Klotho//1a(OH)ase/ double-mutant mice, suggesting
that the effect of klotho on erythroid cell production is inde-
pendent of vitamin D levels. However, the low mean cell
hemoglobin content and microcytosis were normalized in the
double-mutant mice, indicating a possible involvement of
vitamin D in maintaining normal RBC size. To our knowl-
edge, there are no data available directly linking vitamin D to
RBC mass, and the role of 1,25-dihydroxyvitamin D3 in the
proliferation of erythroid precursors has been controver-
sial.85,86 Moreover, studies have shown that increased intra-
cellular calcium levels in circulating RBCs result in a decrease
in RBC volume.87 This is caused by activation of calcium
channels present in RBCs, leading to RBC membrane
deformation and a subsequent increase in Ca2þ permeability,
inducing signiﬁcant cell dehydration and cell shrinkage.87
Therefore, it is possible that the effect on MCV in Klotho/
mice ismediated by the hypercalcemia that thesemice exhibit.
Further studies are needed to determine whether calcium
plays a role in the effects of klotho on erythropoiesis. In
addition, genetic ablation of 1a(OH)ase resulted in normal
numbers of BM hematopoietic progenitor cells (LSK;
LinSca-1þcKitþ) compared with Klotho/ mice, suggest-
ing that high vitamin D levels associated with klotho deﬁ-
ciency may be responsible for the decline in HSC numbers.
The prevalence of anemia in patients with CKD is mainly
attributed to reduced renal Epo production. Klotho expres-
sion is also reduced with kidney disease progression.18
However, we found that klotho deﬁciency in mice is asso-
ciated with up-regulation in renal Epo production. It has
been shown that Epo levels are increased with aging, as a
compensation for increased erythrocyte turnover.88,89 With
advanced aging, however, this compensatory mechanism
eventually becomes inadequate, leading to the development
of anemia.89 Moreover, previous studies have demonstrated
that in the aging kidney, HIF signaling is activated by
hypoxia, resulting in the coordinated induction of HIF-
regulated genes, such as Epo and Glut-1.54 Therefore, the
aging-related changes in Klotho-null mice may be partially
responsible for the elevated Epo production and increased
erythropoiesis in these mice. Furthermore, patients with
CKD exhibit low serum levels of vitamin D,90 whereas
Klotho-null mice have signiﬁcantly elevated vitamin D
levels.59 It has been shown that 1,25-dihydroxyvitamin D3ajp.amjpathol.org - The American Journal of Pathology
Klotho Regulates Hematopoiesisinduces up-regulation of Epo-R expression followed by
stimulation of the growth and proliferation of erythroid
precursor cells.91 In addition, it has been previously reported
that the hematon fraction of normal BM, a low-density
ﬂoating layer that constitutes the most productive erythro-
poietic compartment, contains signiﬁcantly high active
vitamin D content.92 Therefore, it would be tempting to
speculate that excess vitamin D in Klotho/ mice may have
also induced erythroid activity. However, the present
ﬁnding that increased erythropoiesis in Klotho/ mice was
not affected by genetic ablation of 1a(OH)ase suggests that
it is most likely a vitamin Deindependent process. Further
studies are required to address the exact mechanism of
enhanced erythropoiesis associated with klotho deﬁciency.
In addition, exogenous administration of klotho resulted
in hematopoietic changes opposite to the ones observed in
Klotho-deﬁcient mice. Based on these observations, the
present study demonstrates for the ﬁrst time that klotho
directly regulates HSC differentiation and erythroid cell
generation and maturation. Moreover, we observed that
klotho deﬁciency affected the prenatal fetal liver erythroid
compartment in a similar manner, clearly suggesting a novel
function for klotho in the regulation of hematopoiesis
beyond the skeletal abnormalities and senescence features
ascribed to its deﬁciency. Embryonic hematopoiesis begins
in the yolk sac and moves to the aorta-gonad-mesonephros
region, followed by the fetal liver, which becomes the pri-
mary site of fetal hematopoiesis.93,94 The present ﬁndings
that klotho expression is detected in fetal liver cells from
WT mice and that loss of klotho results in hematopoietic
changes in fetal liver similar to the ones observed in adult
mice are crucial. These data strongly suggest that aberrant
production or function of HSCs in Klotho-null mice occurs
before translocation of HSCs from fetal liver to BM, linking
klotho directly to the development of hematopoiesis. Given
that fetal liver does not generate HSCs but rather serves as a
remarkable organ for HSC expansion, the changes we
confront may be due to events upstream of the fetal liver,
suggesting an exciting possibility of klotho having a func-
tion in embryonic hematopoietic development. Additional
studies are required to determine the role of klotho in
migration and colonization of the fetal liver and the mech-
anisms of action of klotho in prenatal hematopoiesis.
In summary, the present observations show that klotho
deﬁciency not only plays a role in aging and aging-related
conditions, such as CKD, CVD, and osteopenia, but also
severely affects hematopoietic development, suggesting that
the therapeuticmanipulationof klothohas considerable clinical
implications. Taken as a whole, this study identiﬁes klotho as a
potent regulator of prenatal and postnatal hematopoiesis and
provides clear evidence that it plays an essential role in he-
matopoietic development. The ﬁndings herein extend our
knowledge of the processes participating in establishment of
the HSC niche and provide a better understanding of the con-
nections among renal function, bone development, hemato-
poiesis, and aging. Moreover, therapeutic targeting of klothoThe American Journal of Pathology - ajp.amjpathol.organd its associated signaling components may serve as a
mechanism to boost immune functions and treat blood cell
disorders associated with aging or kidney disorders.
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